OMEPRAZOLE EXTENDED-RELEASE CAPSULES

The Defense Logistics Agency awarded a delivery order under contract SPE2DX25D9900 to DMS PHARMACEUTICAL GROUP INC, with CAGE code 1UNB0, for the supply of 2,000 bottles of OMEPRAZOLE EXTENDED-RELEASE CAPSULES identified by NSN 6505016247068 and NDC 00781-2868-92. The contract, issued on July 2, 2026, carries a fixed total price of $101.60 with no variance allowed in quantity, indicating a strictly defined one-time delivery. The item must be delivered to W33RBS, Building 1509, West 6th Street, Fort Stewart, Georgia, 31314-5185, with FOB destination terms placing full responsibility for transportation and payment on the contractor. Shipping must occur via the fastest traceable means, explicitly prohibiting Parcel Post, and all packages must bear the CAGE code OTHL4, NSN, part number, transport control number W33RBS61820379, and required delivery date 182. Inspection and acceptance occur at the destination point, with no formal quality or inspection standards cited beyond the use of the NSN and inclusion in the DLA supply chain, which implies compliance with applicable pharmaceutical procurement requirements. The manufacturer’s CAGE code is OTHL4, and while the NAICS code 325412 is listed for pharmaceutical preparation manufacturing, no socioeconomic status, size certification, or subcontracting plan information is provided. The contract does not reference any specific MIL-STDs for packaging or preservation, nor does it include formal FAR clauses, evaluation factors, or point-of-contact details for administrative or technical oversight. Payment responsibility lies with the contractor under FOB destination terms, and while financial identifiers such as PR number 7017382746, DIC code A0A, and FC code Z9 are included, no remit-to address, invoice submission method, or contracting officer contact information is specified. The award is a direct, single-line-item procurement with no options, modifications, or stated basis for selection beyond price, consistent with a low-dollar-value, firm-fixed-price acquisition.